MT2021-08T

T-cell receptor alpha/beta-depleted donor peripheral blood stem cell product · Masonic Cancer Center, University of Minnesota

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MT2021-08T, covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies [Phase 2]